Thus, the Signia surgical stapling system was born. The Signia was designed with built-in smart technology to detect the ...

For years, investors questioned whether Medtronic was moving quickly and innovating enough. Now, the company is answering with its checkbook. So far in 2026, the Minnesota-run medical device maker has ...

Medtronic gains attention as renal denervation optimism, revenue growth, cardiac care, and diabetes technology reshape its ...

Medtronic issued a voluntary global recall of its Octopus 4 Tissue Stabilizer after identifying an assembly issue during ...

Medtronic announced today the launch of CareLink Mobile Application, which the company calls the first mobile application that pairs with implantable cardiac devices. The app is available for the ...

Medtronic (MDT) ended the recent trading session at $83.87, demonstrating a +1.8% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.

With 60 hedge funds holding bullish positions and analysts seeing 19.84% upside potential, Medtronic plc (NYSE:MDT) ranks among the top stocks to buy for financial stability. Medtronic plc (NYSE:MDT) ...

(Reuters) - Medical technology company Medtronic PLC has asked a U.S. judge in California to dismiss as "threadbare" an antitrust lawsuit from rival device manufacturer Applied Medical Resources Corp ...

Medtronic delivered $36.4B in revenue, the strongest growth in a decade, led by Cardiovascular and ablation solutions. Learn ...

Medtronic stock is a "Buy" given its premium-margin medtech, diversification, accelerated growth, and undervalued shares.